174 related articles for article (PubMed ID: 12833144)
1. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells.
Derry JJ; Prins GS; Ray V; Tyner AL
Oncogene; 2003 Jul; 22(27):4212-20. PubMed ID: 12833144
[TBL] [Abstract][Full Text] [Related]
2. BRK/Sik expression in the gastrointestinal tract and in colon tumors.
Llor X; Serfas MS; Bie W; Vasioukhin V; Polonskaia M; Derry J; Abbott CM; Tyner AL
Clin Cancer Res; 1999 Jul; 5(7):1767-77. PubMed ID: 10430081
[TBL] [Abstract][Full Text] [Related]
3. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability.
Derry JJ; Richard S; Valderrama Carvajal H; Ye X; Vasioukhin V; Cochrane AW; Chen T; Tyner AL
Mol Cell Biol; 2000 Aug; 20(16):6114-26. PubMed ID: 10913193
[TBL] [Abstract][Full Text] [Related]
4. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.
Haegebarth A; Heap D; Bie W; Derry JJ; Richard S; Tyner AL
J Biol Chem; 2004 Dec; 279(52):54398-404. PubMed ID: 15471878
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
Lukong KE; Larocque D; Tyner AL; Richard S
J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
[TBL] [Abstract][Full Text] [Related]
6. Expression of a truncated form of the c-Kit tyrosine kinase receptor and activation of Src kinase in human prostatic cancer.
Paronetto MP; Farini D; Sammarco I; Maturo G; Vespasiani G; Geremia R; Rossi P; Sette C
Am J Pathol; 2004 Apr; 164(4):1243-51. PubMed ID: 15039213
[TBL] [Abstract][Full Text] [Related]
7. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells.
Wang TC; Jee SH; Tsai TF; Huang YL; Tsai WL; Chen RH
Br J Dermatol; 2005 Aug; 153(2):282-9. PubMed ID: 16086737
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells.
Brauer PM; Zheng Y; Wang L; Tyner AL
Cell Cycle; 2010 Oct; 9(20):4190-9. PubMed ID: 20953141
[TBL] [Abstract][Full Text] [Related]
9. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium.
Petro BJ; Tan RC; Tyner AL; Lingen MW; Watanabe K
Oral Oncol; 2004 Nov; 40(10):1040-7. PubMed ID: 15509496
[TBL] [Abstract][Full Text] [Related]
11. A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract.
Vasioukhin V; Serfas MS; Siyanova EY; Polonskaia M; Costigan VJ; Liu B; Thomason A; Tyner AL
Oncogene; 1995 Jan; 10(2):349-57. PubMed ID: 7838533
[TBL] [Abstract][Full Text] [Related]
12. A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation.
Vasioukhin V; Tyner AL
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14477-82. PubMed ID: 9405638
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
15. Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration.
Lukong KE; Richard S
Cell Signal; 2008 Feb; 20(2):432-42. PubMed ID: 18077133
[TBL] [Abstract][Full Text] [Related]
16. The intracellular tyrosine kinase Brk sensitizes non-transformed cells to inducers of apoptosis.
Haegebarth A; Nunez R; Tyner AL
Cell Cycle; 2005 Sep; 4(9):1239-46. PubMed ID: 16082217
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of the cell cycle by breast tumor kinase (Brk).
Chan E; Nimnual AS
Int J Cancer; 2010 Dec; 127(11):2723-31. PubMed ID: 20162673
[TBL] [Abstract][Full Text] [Related]
18. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.
Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL
PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203
[TBL] [Abstract][Full Text] [Related]
19. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases.
Serfas MS; Tyner AL
Oncol Res; 2003; 13(6-10):409-19. PubMed ID: 12725532
[TBL] [Abstract][Full Text] [Related]
20. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation.
Kamalati T; Jolin HE; Fry MJ; Crompton MR
Oncogene; 2000 Nov; 19(48):5471-6. PubMed ID: 11114724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
